CLINICAL_TRIALS
trial_result
· 2019-01-23
Clinical Trial Update: Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease [Phase 3]
Summary
Phase 3 trial of Mongersen (GED-0301) for active Crohn's disease was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Crohn Disease | Phase 3 | Status: TERMINATED | Results posted: 2019-01-23